4.7 Article

Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response

Bashkim Kadriu et al.

Summary: This study explored the impact of ketamine on the endogenous KYN pathway in individuals with bipolar depression and its relationship with depression-related behavioral and peripheral inflammatory markers. Results showed that post-ketamine IDO levels were significantly lower, while KYN and KynA levels were significantly increased. Inflammatory markers and behavioral measures predicted changes in the KYN pathway post ketamine treatment.

MOLECULAR PSYCHIATRY (2021)

Article Medicine, General & Internal

Evidence that a deviation in the kynurenine pathway aggravates atherosclerotic disease in humans

R. Baumgartner et al.

Summary: The study elucidates the potential role of the kynurenine pathway in human atherosclerosis through multiplatform analysis of tissue samples. It reveals that deviation in the kynurenine pathway is associated with an increased probability of developing symptomatic unstable atherosclerotic disease, with important implications for the regulation of vascular inflammation.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Endocrinology & Metabolism

Kynurenine-Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia

Itzel Y. Rojas et al.

Summary: The study found that Kyn can activate AHR in mice to induce obesity, fatty liver, and hyperglycemia, and in female patients, a significant association between Kyn and age was observed in patients with obesity. The results indicate that an activated AHR is necessary for obesity, fatty liver, and hyperglycemia, and plasma Kyn levels increase with age in women with obesity.

OBESITY (2021)

Review Biochemistry & Molecular Biology

The kynurenine pathway: a finger in every pie

Jonathan Savitz

MOLECULAR PSYCHIATRY (2020)

Article Geriatrics & Gerontology

Polycystic ovary syndrome and aging: Health implications after menopause

Nafiye Helvaci et al.

MATURITAS (2020)

Article Biochemistry & Molecular Biology

Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique

Magdalena Buszewska-Forajta et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2019)

Review Biotechnology & Applied Microbiology

Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

Michael Platten et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Endocrinology & Metabolism

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

Panagiotis Anagnostis et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2018)

Article Cell Biology

Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation

Leandro Z. Agudelo et al.

CELL METABOLISM (2018)

Article Biochemistry & Molecular Biology

Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health

Ludivine Laurans et al.

NATURE MEDICINE (2018)

Review Endocrinology & Metabolism

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

Hector F. Escobar-Morreale

NATURE REVIEWS ENDOCRINOLOGY (2018)

Article Clinical Neurology

IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity

Adriano Jose Maia Chaves Filho et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)

Review Endocrinology & Metabolism

Obesity as disruptor of the female fertility

Erica Silvestris et al.

REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2018)

Review Multidisciplinary Sciences

Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health

Igor Cervenka et al.

SCIENCE (2017)

Review Obstetrics & Gynecology

Criteria, prevalence, and phenotypes of polycystic ovary syndrome

Daria Lizneva et al.

FERTILITY AND STERILITY (2016)

Review Obstetrics & Gynecology

Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis

Negar Naderpoor et al.

HUMAN REPRODUCTION UPDATE (2015)

Article Neurosciences

Increased Plasma Levels of Xanthurenic and Kynurenic Acids in Type 2 Diabetes

Gregory F. Oxenkrug

MOLECULAR NEUROBIOLOGY (2015)

Review Endocrinology & Metabolism

Metabolic risk in PCOS: phenotype and adiposity impact

Lisa J. Moran et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)

Article Biochemistry & Molecular Biology

Association Between Polycystic Ovary Syndrome and Metabolic Syndrome

Leandro Martin Velez et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Article Obstetrics & Gynecology

Hyperandrogenism during puberty in the development of polycystic ovary syndrome

Shahla Nader

FERTILITY AND STERILITY (2013)

Article Medicine, Research & Experimental

Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression

Hyangin Kim et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Biochemistry & Molecular Biology

Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity

Robert Owe-Young et al.

JOURNAL OF NEUROCHEMISTRY (2008)

Article Endocrinology & Metabolism

Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature

R Azziz

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)